EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression

Chenyu Wang, Xingwang Li, Junjie Zhang, Zheng Ge, Hejin Chen, Junhong Hu

DOI: 10.2147/ott.s180131
Published: 2018-11
Container: OncoTargets and Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ott.s180131,
  title = {EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression},
  author = {Chenyu Wang and Xingwang Li and Junjie Zhang and Zheng Ge and Hejin Chen and Junhong Hu},
  year = {2018},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s180131},
  url = {https://doi.org/10.2147/ott.s180131}
}

RIS

TY  - JOUR
TI  - EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
AU  - Chenyu Wang
AU  - Xingwang Li
AU  - Junjie Zhang
AU  - Zheng Ge
AU  - Hejin Chen
AU  - Junhong Hu
PY  - 2018
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s180131
UR  - https://doi.org/10.2147/ott.s180131
ER  -

APA

Wang, C., Li, X., Zhang, J., Ge, Z., Chen, H., & Hu, J. (2018). EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression. OncoTargets and Therapy. https://doi.org/10.2147/ott.s180131

Source records

crossref · retrieved 2026-09-24T20:41:24.486Z